- Home
- RDHL vs DOMH Comparison
RDHL vs DOMH Comparison
Compare RDHL & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDHL
- DOMH
- Stock Information
- Founded
- RDHL 2009
- DOMH 1967
- Country
- RDHL Israel
- DOMH United States
- Employees
- RDHL N/A
- DOMH N/A
- Industry
- RDHL Biotechnology: Pharmaceutical Preparations
- DOMH Biotechnology: Pharmaceutical Preparations
- Sector
- RDHL Health Care
- DOMH Health Care
- Exchange
- RDHL Nasdaq
- DOMH Nasdaq
- Market Cap
- RDHL 4.3M
- DOMH 74.7M
- IPO Year
- RDHL N/A
- DOMH N/A
- Fundamental
- Price
- RDHL $2.18
- DOMH $5.33
- Analyst Decision
- RDHL
- DOMH
- Analyst Count
- RDHL 0
- DOMH 0
- Target Price
- RDHL N/A
- DOMH N/A
- AVG Volume (30 Days)
- RDHL 17.8K
- DOMH 288.5K
- Earning Date
- RDHL 08-28-2025
- DOMH 08-07-2025
- Dividend Yield
- RDHL N/A
- DOMH 5.98%
- EPS Growth
- RDHL N/A
- DOMH N/A
- EPS
- RDHL N/A
- DOMH N/A
- Revenue
- RDHL $8,042,999.00
- DOMH $24,891,000.00
- Revenue This Year
- RDHL $381.91
- DOMH N/A
- Revenue Next Year
- RDHL N/A
- DOMH N/A
- P/E Ratio
- RDHL N/A
- DOMH N/A
- Revenue Growth
- RDHL 23.17
- DOMH 630.80
- 52 Week Low
- RDHL $1.71
- DOMH $0.83
- 52 Week High
- RDHL $20.28
- DOMH $13.58
- Technical
- Relative Strength Index (RSI)
- RDHL 65.22
- DOMH 44.76
- Support Level
- RDHL $2.00
- DOMH $4.94
- Resistance Level
- RDHL $2.08
- DOMH $5.21
- Average True Range (ATR)
- RDHL 0.09
- DOMH 0.40
- MACD
- RDHL 0.03
- DOMH -0.08
- Stochastic Oscillator
- RDHL 97.73
- DOMH 0.64
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.